Editco Bio Inc.
Redwood City, CA
- UEI
- MN9PSNE16SJ8
- CAGE
- 9Z0W3
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 600 Saginaw Dr, Redwood City, CA 94063, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Hibit-tagged FLT3 cell line | National Center for Advancing Translational Sciences | $14,857 | |
| 2 SFRP1-hibit-tagged cell lines for small molecule screening | National Institute on Drug Abuse | $24,150 | |
| Synthego:1293873 [24-007185] | National Institute on Drug Abuse | $35,000 | |
| 24-016468 DR. Martina requires knock-in cell line generation services in order to perform cell biology experiments | National Heart Lung and Blood Institute | $11,450 |
About Editco Bio Inc.
Editco Bio Inc. is a self-certified small disadvantaged business headquartered in Redwood City, California, that specializes in advanced biomedical research services with a focus on cell line generation and genetic modification. Registered with SAM.gov in July 2024, the company provides specialized biological research materials and services to federal scientific agencies, positioning itself as a reliable vendor for complex cellular engineering projects that support translational science and drug discovery initiatives.
Editco Bio Inc. has secured four federal contract awards totaling $85,457, all issued as firm fixed-price purchase orders without set-aside designations. The National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health, has been the company's primary funding partner, awarding three contracts valued at $74,007. These NCATS contracts, awarded between September 2024 and September 2025, encompassed the delivery of specialized engineered cell lines including HIBIT-tagged FLT3 cell lines ($14,857), SFRP1-HIBIT-tagged cell lines for small molecule screening ($24,150), and a Synthego product ($35,000). Additionally, the National Heart Lung and Blood Institute awarded a $11,450 purchase order in August 2024 for knock-in cell line generation services to support Dr. Martina's cell biology experiments. Collectively, these contracts demonstrate Editco Bio Inc.'s expertise in providing precisely engineered cell models with specialized tagging and genetic modifications, designed to support downstream pharmaceutical screening, biomedical research, and translational science applications across multiple federal research institutes.
Quick answers
What is Editco Bio Inc.'s UEI?
Editco Bio Inc.'s Unique Entity ID (UEI) in SAM.gov is MN9PSNE16SJ8.
What is Editco Bio Inc.'s CAGE code?
Editco Bio Inc.'s CAGE code is 9Z0W3.
What is Editco Bio Inc.'s primary NAICS code?
Editco Bio Inc.'s primary NAICS code is 541715 (Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)).
Where is Editco Bio Inc. located?
Editco Bio Inc.'s physical address in SAM.gov is 600 Saginaw Dr, Redwood City, CA 94063, USA.
Is Editco Bio Inc. registered in SAM.gov?
Yes. Editco Bio Inc.'s SAM.gov registration is active through August 26, 2027.
What is Editco Bio Inc.'s most recent federal award?
Editco Bio Inc.'s most recent federal contract award is Hibit-tagged FLT3 cell line (75N95C25P00096), from National Center for Advancing Translational Sciences, on September 4, 2025.
On GovTribe
See Editco Bio Inc.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors